PAVmed Inc. Files 8-K: Financials & Reg FD Update
Ticker: PAVM · Form: 8-K · Filed: Mar 30, 2026 · CIK: 0001624326
Sentiment: neutral
Topics: financial-results, regulation-fd, filing
TL;DR
PAVmed dropped an 8-K with financial results and Reg FD news. Check it out.
AI Summary
PAVmed Inc. filed an 8-K on March 30, 2026, reporting on its Results of Operations and Financial Condition, and making Regulation FD disclosures. The filing includes financial statements and exhibits, with the company's mailing and business address listed as 360 Madison Avenue, New York, NY 10017.
Why It Matters
This 8-K filing provides crucial updates on PAVmed Inc.'s financial performance and regulatory disclosures, which are important for investors to assess the company's current standing.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price, requiring careful review.
Key Players & Entities
- PAVmed Inc. (company) — Filer of the 8-K
- 0001624326 (company) — CIK number for PAVmed Inc.
- 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 (company) — Mailing and Business Address for PAVmed Inc.
- 2026-03-30 (date) — Filing Date and Period of Report
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates Item 2.02: Results of Operations and Financial Condition, but the specific financial figures are not detailed in the provided summary text.
What is the purpose of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, preventing selective disclosure.
What are the key documents included in this 8-K filing?
The filing includes the 8-K form itself, an exhibit (EX-99.1), a complete submission text file, and XBRL data files.
What is PAVmed Inc.'s SIC code and industry classification?
PAVmed Inc.'s SIC code is 3841, classifying it under Surgical & Medical Instruments & Apparatus.
Where is PAVmed Inc. located based on the filing?
PAVmed Inc.'s mailing and business address is 360 Madison Avenue, 25th Floor, New York, NY 10017.
Filing Stats: 512 words · 2 min read · ~2 pages · Grade level 9.3 · Accepted 2026-03-30 08:10:19
Key Financial Figures
- $0.001 — ch registered Common Stock, Par Value $0.001 Per Share PAVM The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 89KB
- 0001493152-26-013477.txt ( ) — 300KB
- pavm-20260330.xsd (EX-101.SCH) — 3KB
- pavm-20260330_lab.xml (EX-101.LAB) — 33KB
- pavm-20260330_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On March 30, 2026, PAVmed Inc. (the " Company ") issued a press release announcing financial results for its fiscal year ended December 31, 2025 and providing a business update. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated herein by reference. Item 7.01. Regulation FD Disclosure. The disclosure set forth under Item 2.02 is incorporated herein by reference. The information furnished under Items 2.02 and 7.01, including the exhibit related thereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document. Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 30, 2026 PAVMED INC. By: /s/ Dennis McGrath Dennis McGrath President and Chief Financial Officer